Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10044531HBVENSG00000126934.15protein_codingMAP2K2YesNo5605P36507
TVIS30004704HIVENSG00000126934.15protein_codingMAP2K2YesNo5605P36507
TVIS30012505HIVENSG00000126934.15protein_codingMAP2K2YesNo5605P36507
TVIS30047381HIVENSG00000126934.15protein_codingMAP2K2YesNo5605P36507
TVIS30047382HIVENSG00000126934.15protein_codingMAP2K2YesNo5605P36507
TVIS30047383HIVENSG00000126934.15protein_codingMAP2K2YesNo5605P36507
TVIS30047384HIVENSG00000126934.15protein_codingMAP2K2YesNo5605P36507
TVIS30047385HIVENSG00000126934.15protein_codingMAP2K2YesNo5605P36507
TVIS30047386HIVENSG00000126934.15protein_codingMAP2K2YesNo5605P36507
TCGA Plot Options
Drug Information
GeneMAP2K2
DrugBank IDDB11967
Drug NameBinimetinib
Target IDBE0004744
UniProt IDP36507
Regulation Typeinhibitor
PubMed IDs28587477
CitationsKoelblinger P, Dornbierer J, Dummer R: A review of binimetinib for the treatment of mutant cutaneous melanoma. Future Oncol. 2017 Aug;13(20):1755-1766. doi: 10.2217/fon-2017-0170. Epub 2017 Jun 7.
GroupsApproved; Investigational
Direct Classification3-halobenzoic acids and derivatives
SMILESCN1C=NC2=C(F)C(NC3=CC=C(Br)C=C3F)=C(C=C12)C(=O)NOCCO
Pathways
PharmGKBPA166179867
ChEMBLCHEMBL3187723